TG THERAPEUTICS, INC. Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations
TG THERAPEUTICS, INC. (TGTX) reported Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations of -$41.65 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems · last filed 2023-03-01
- TG THERAPEUTICS, INC. income tax expense (benefit), continuing operations, discontinued operations for fiscal 2022 was -$41.65M.
- TG THERAPEUTICS, INC. income tax expense (benefit), continuing operations, discontinued operations for fiscal 2021 was -$73.10M.
- TG THERAPEUTICS, INC. income tax expense (benefit), continuing operations, discontinued operations for fiscal 2020 was -$58.67K.
- TG THERAPEUTICS, INC. income tax expense (benefit), continuing operations, discontinued operations for fiscal 2019 was -$36.30K.
| Period end | Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations 12 month | Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations 12 month as first filed |
|---|---|---|
| 2022-12-31 | -$41.65M 10-K · filed 2023-03-01 | |
| 2021-12-31 | -$73.10M 10-K · filed 2023-03-01 | |
| 2020-12-31 | -$58.67K 10-K · filed 2023-03-01 | -$58.67M 10-K · filed 2021-03-01 |
| 2019-12-31 | -$36.30K 10-K · filed 2022-03-01 | -$36.30M 10-K · filed 2020-03-02 |
| 2018-12-31 | -$36.43K 10-K · filed 2021-03-01 | -$36.43M 10-K · filed 2019-03-01 |
| 2017-12-31 | -$40.28K 10-K · filed 2020-03-02 | -$40.28M 10-K · filed 2018-03-15 |
| 2016-12-31 | -$26.61M 10-K · filed 2019-03-01 | -$26.61M 10-K · filed 2017-03-16 |
| 2015-12-31 | -$21.40M 10-K · filed 2018-03-15 | |
| 2014-12-31 | -$18.97M 10-K · filed 2017-03-16 | |
| 2013-12-31 | -$6.96M 10-K · filed 2016-03-15 | |
| 2012-12-31 | -$8.79M 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |